
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.7B | $1.9B | $2.3B | $2.3B | |
Revenue Growth (YoY) | -9.18% | 2.55% | 10.85% | 19.82% | 0.61% | |
Cost of Revenues | $1.1B | $1.1B | $1.3B | $1.5B | $1.5B | |
Gross Profit | $605.4M | $619.7M | $609.8M | $762.6M | $771.1M | |
Gross Profit Margin | 35.86% | 35.8% | 31.78% | 33.17% | 33.33% | |
R&D Expenses | $115.9M | $117.8M | $133.3M | $154.4M | $181.5M | |
Selling, General & Admin | $90M | $92.2M | $106.5M | $112.5M | $121M | |
Other Inc / (Exp) | $12.3M | $6.6M | -$283.1K | $9.3M | $3.6M | |
Operating Expenses | $205.9M | $209.9M | $239.8M | $266.9M | $302.5M | |
Operating Income | $399.6M | $409.8M | $370M | $495.7M | $468.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $411.8M | $416.4M | $369.7M | $505M | $472.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $64.2M | $55.6M | $51M | $76.6M | $67.7M | |
Net Income to Company | $347.6M | $360.8M | $318.8M | $428.4M | $404.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $347.6M | $360.8M | $318.8M | $428.4M | $404.5M | |
Basic EPS (Cont. Ops) | $1.41 | $1.51 | $1.36 | $1.84 | $1.77 | |
Diluted EPS (Cont. Ops) | $1.41 | $1.50 | $1.36 | $1.84 | $1.76 | |
Weighted Average Basic Share | $242.6M | $235.5M | $230.8M | $229.4M | $225.7M | |
Weighted Average Diluted Share | $243.7M | $236.6M | $231.2M | $229.7M | $226M | |
EBITDA | $504.3M | $508.9M | $466.6M | $589.1M | $563.3M | |
EBIT | $399.6M | $409.8M | $370M | $495.7M | $468.6M | |
Revenue (Reported) | $1.7B | $1.7B | $1.9B | $2.3B | $2.3B | |
Operating Income (Reported) | $399.6M | $409.8M | $370M | $495.7M | $468.6M | |
Operating Income (Adjusted) | $399.6M | $409.8M | $370M | $495.7M | $468.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $483.7M | $468.3M | $550.8M | $590.2M | $576.8M | |
Revenue Growth (YoY) | 6.6% | -3.2% | 17.62% | 7.17% | -2.28% | |
Cost of Revenues | $300.4M | $307.8M | $376M | $388M | $385M | |
Gross Profit | $183.3M | $160.4M | $174.7M | $202.2M | $191.7M | |
Gross Profit Margin | 37.89% | 34.26% | 31.73% | 34.27% | 33.24% | |
R&D Expenses | $27.7M | $32M | $34.7M | $42.2M | $45.9M | |
Selling, General & Admin | $21.9M | $25.1M | $26.8M | $30.7M | $29.9M | |
Other Inc / (Exp) | $1.5M | -$10.5K | $2.7M | -$1.7M | -$2.2M | |
Operating Expenses | $49.6M | $57.1M | $61.5M | $72.9M | $75.9M | |
Operating Income | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $135.3M | $103.3M | $116M | $127.6M | $113.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $21.8M | $15.8M | $18.4M | $19.4M | $18.8M | |
Net Income to Company | $113.5M | $87.5M | $97.6M | $108.2M | $94.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $113.5M | $87.5M | $97.6M | $108.2M | $94.9M | |
Basic EPS (Cont. Ops) | $0.47 | $0.37 | $0.42 | $0.47 | $0.42 | |
Diluted EPS (Cont. Ops) | $0.46 | $0.37 | $0.42 | $0.47 | $0.42 | |
Weighted Average Basic Share | $239.6M | $232.2M | $232.2M | $230.6M | $223.5M | |
Weighted Average Diluted Share | $241.7M | $232.8M | $232.8M | $230.9M | $223.6M | |
EBITDA | $159.3M | $128M | $137.3M | $153.3M | $141.4M | |
EBIT | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M | |
Revenue (Reported) | $483.7M | $468.3M | $550.8M | $590.2M | $576.8M | |
Operating Income (Reported) | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M | |
Operating Income (Adjusted) | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.7B | $2B | $2.3B | $2.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.1B | $1.1B | $1.4B | $1.5B | $1.5B | |
Gross Profit | $632.2M | $596.8M | $624.1M | $790.1M | $760.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $114M | $122.1M | $136M | $161.9M | $185.2M | |
Selling, General & Admin | $89.9M | $95.4M | $108.2M | $116.4M | $120.2M | |
Other Inc / (Exp) | $11.5M | $5M | $2.5M | $4.8M | $3.1M | |
Operating Expenses | $203.9M | $217.5M | $244.2M | $278.3M | $305.5M | |
Operating Income | $428.3M | $379.4M | $380M | $511.8M | $455.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $439.8M | $384.4M | $382.4M | $516.6M | $458.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $68.3M | $49.5M | $53.6M | $77.6M | $67.1M | |
Net Income to Company | $371.5M | $334.9M | $328.8M | $439.1M | $391.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $371.5M | $334.9M | $328.8M | $439.1M | $391.1M | |
Basic EPS (Cont. Ops) | $1.53 | $1.41 | $1.41 | $1.89 | $1.72 | |
Diluted EPS (Cont. Ops) | $1.51 | $1.40 | $1.41 | $1.89 | $1.71 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $532.3M | $477.6M | $475.8M | $605.1M | $551.4M | |
EBIT | $428.3M | $379.4M | $380M | $511.8M | $455.1M | |
Revenue (Reported) | $1.7B | $1.7B | $2B | $2.3B | $2.3B | |
Operating Income (Reported) | $428.3M | $379.4M | $380M | $511.8M | $455.1M | |
Operating Income (Adjusted) | $428.3M | $379.4M | $380M | $511.8M | $455.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $483.7M | $468.3M | $550.8M | $590.2M | $576.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $300.4M | $307.8M | $376M | $388M | $385M | |
Gross Profit | $183.3M | $160.4M | $174.7M | $202.2M | $191.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $27.7M | $32M | $34.7M | $42.2M | $45.9M | |
Selling, General & Admin | $21.9M | $25.1M | $26.8M | $30.7M | $29.9M | |
Other Inc / (Exp) | $1.5M | -$10.5K | $2.7M | -$1.7M | -$2.2M | |
Operating Expenses | $49.6M | $57.1M | $61.5M | $72.9M | $75.9M | |
Operating Income | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $135.3M | $103.3M | $116M | $127.6M | $113.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $21.8M | $15.8M | $18.4M | $19.4M | $18.8M | |
Net Income to Company | $113.5M | $87.5M | $97.6M | $108.2M | $94.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $113.5M | $87.5M | $97.6M | $108.2M | $94.9M | |
Basic EPS (Cont. Ops) | $0.47 | $0.37 | $0.42 | $0.47 | $0.42 | |
Diluted EPS (Cont. Ops) | $0.46 | $0.37 | $0.42 | $0.47 | $0.42 | |
Weighted Average Basic Share | $239.6M | $232.2M | $232.2M | $230.6M | $223.5M | |
Weighted Average Diluted Share | $241.7M | $232.8M | $232.8M | $230.9M | $223.6M | |
EBITDA | $159.3M | $128M | $137.3M | $153.3M | $141.4M | |
EBIT | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M | |
Revenue (Reported) | $483.7M | $468.3M | $550.8M | $590.2M | $576.8M | |
Operating Income (Reported) | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M | |
Operating Income (Adjusted) | $133.7M | $103.3M | $113.3M | $129.3M | $115.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $423.4M | $262.3M | $214.8M | $226.4M | $233.3M | |
Short Term Investments | $27.2M | $5.4M | $23M | $14.4M | $22.3M | |
Accounts Receivable, Net | $284.9M | $249.8M | $276.5M | $321.8M | $295.3M | |
Inventory | $226.3M | $316.3M | $404.4M | $402.5M | $436.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $17.6M | $39.2M | $26M | $32.7M | $49.9M | |
Total Current Assets | $979.3M | $873M | $948.7M | $997.7M | $1B | |
Property Plant And Equipment | $468.1M | $464.1M | $550M | $652.9M | $728.5M | |
Long-Term Investments | $162M | $207.7M | $202.3M | $299.1M | $339.6M | |
Goodwill | $311.9M | $314M | $313.8M | $340.1M | $340.7M | |
Other Intangibles | $276.5M | $267.8M | $286.9M | $280.5M | $261.6M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.2B | $2.1B | $2.3B | $2.6B | $2.8B | |
Accounts Payable | $84.8M | $98.3M | $151.7M | $184.4M | $168.3M | |
Accrued Expenses | $59.9M | $54.7M | $52M | $58.7M | $56.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $177.7M | $181.7M | $250.6M | $271.6M | $252.7M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $234M | $193.4M | $261.4M | $298.9M | $288.7M | |
Common Stock | $14.6M | $14.2M | $14.1M | $13.9M | $13.6M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $2B | $1.9B | $2.1B | $2.3B | $2.5B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | $4.1M | |
Total Equity | $2B | $1.9B | $2.1B | $2.3B | $2.5B | |
Total Liabilities and Equity | $2.2B | $2.1B | $2.3B | $2.6B | $2.8B | |
Cash and Short Terms | $450.5M | $267.7M | $237.8M | $240.8M | $255.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $455.9M | $279.7M | $215.5M | $249M | $286.6M | |
Short Term Investments | $25.9M | $6.9M | $25.6M | $16.8M | $20.5M | |
Accounts Receivable, Net | $277.7M | $281.5M | $332.9M | $341.6M | $330.6M | |
Inventory | $233.1M | $362.7M | $401.8M | $436.5M | $408.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $17.9M | $24.7M | $25.3M | $28.7M | $42M | |
Total Current Assets | $1B | $955.5M | $1B | $1.1B | $1.1B | |
Property Plant And Equipment | $460.6M | $468.4M | $575.3M | $664.8M | $734.6M | |
Long-Term Investments | $172.9M | $175.8M | $229.4M | $311M | $300.6M | |
Goodwill | $314.7M | $313.9M | $313.7M | $340.1M | $340.7M | |
Other Intangibles | $283.7M | $247.1M | $286.2M | $280M | $264.4M | |
Other Long-Term Assets | -- | $19.6M | -- | -- | -- | |
Total Assets | $2.2B | $2.2B | $2.4B | $2.7B | $2.8B | |
Accounts Payable | $107.1M | $140.9M | $166.9M | $191.7M | $162.9M | |
Accrued Expenses | $116.2M | $98.3M | $130.1M | $112.7M | $103.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $223.2M | $239.2M | $297M | $304.4M | $266.6M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $281.5M | $251.4M | $310.1M | $336.9M | $303.1M | |
Common Stock | $14.5M | $14.1M | $14M | $13.9M | $13.5M | |
Other Common Equity Adj | $2M | -$5.1M | -$12.2M | -$7.5M | -$5M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | $4.6M | |
Total Equity | $2B | $1.9B | $2.1B | $2.4B | $2.5B | |
Total Liabilities and Equity | $2.2B | $2.2B | $2.4B | $2.7B | $2.8B | |
Cash and Short Terms | $481.9M | $286.6M | $241.1M | $265.8M | $307.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $347.6M | $360.8M | $318.8M | $428.4M | $404.5M | |
Depreciation & Amoritzation | $104.7M | $99.1M | $96.6M | $93.3M | $94.7M | |
Stock-Based Compensation | $30.8M | $27.4M | $30.2M | $39.2M | $39.5M | |
Change in Accounts Receivable | -$49.3M | $35.1M | -$26.7M | -$45.3M | $27.1M | |
Change in Inventories | $22.7M | -$90M | -$88.1M | $2.1M | -$32.6M | |
Cash From Operations | $464.5M | $362.2M | $338.2M | $537.2M | $498.2M | |
Capital Expenditures | $51.7M | $68.8M | $146.4M | $183.7M | $144.7M | |
Cash Acquisitions | -$11.2M | -$25M | -$45.7M | -$90M | -$30.5M | |
Cash From Investing | $26.4M | -$113.1M | -$172.7M | -$299.4M | -$202.1M | |
Dividends Paid (Ex Special Dividend) | -$117.2M | -$115.3M | -$113.1M | -$112.2M | -$110.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $75M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$75M | -- | -- | -- | -- | |
Repurchase of Common Stock | -$288.5M | -$324.6M | -$112.5M | -$147.4M | -$206.1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$363.9M | -$410.1M | -$209M | -$230.2M | -$289.3M | |
Beginning Cash (CF) | $296.3M | $423.4M | $262.3M | $218.8M | $226.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $127M | -$161.1M | -$43.6M | $7.7M | $6.9M | |
Ending Cash (CF) | $423.4M | $262.3M | $218.8M | $226.4M | $233.3M | |
Levered Free Cash Flow | $412.8M | $293.3M | $191.8M | $353.6M | $353.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $113.5M | $87.5M | $97.6M | $108.2M | $94.9M | |
Depreciation & Amoritzation | $25.6M | $24.7M | $24M | $24M | $25.5M | |
Stock-Based Compensation | $5.9M | $6.8M | $8.5M | $10.5M | $8.7M | |
Change in Accounts Receivable | $7.3M | -$31.7M | -$56.4M | -$19.8M | -$35.3M | |
Change in Inventories | -$6.8M | -$46.5M | $2.6M | -$34.1M | $27.6M | |
Cash From Operations | $190.8M | $116M | $120.9M | $129.9M | $148.5M | |
Capital Expenditures | $12.6M | $23.9M | $42.8M | $31.9M | $36.7M | |
Cash Acquisitions | -$12M | -- | -- | -- | -- | |
Cash From Investing | -$40.6M | -$2M | -$72.4M | -$55.1M | -$5.1M | |
Dividends Paid (Ex Special Dividend) | -$29.2M | -$28.6M | -$28.1M | -$27.8M | -$27.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$97.7M | -$71.3M | -$25.7M | -$41.2M | -$67.8M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$117.7M | -$96.5M | -$47.8M | -$52.2M | -$90.2M | |
Beginning Cash (CF) | $423.4M | $262.3M | $218.8M | $226.4M | $233.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $32.6M | $17.4M | $697.5K | $22.6M | $53.2M | |
Ending Cash (CF) | $455.9M | $279.7M | $219.5M | $249M | $286.6M | |
Levered Free Cash Flow | $178.2M | $92.1M | $78.1M | $98M | $111.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $371.5M | $334.9M | $328.8M | $439.1M | $391.1M | |
Depreciation & Amoritzation | $104M | $98.2M | $95.9M | $93.2M | $96.3M | |
Stock-Based Compensation | $30.3M | $28.3M | $32M | $41.2M | $37.7M | |
Change in Accounts Receivable | -$43.9M | -$3.8M | -$51.4M | -$8.7M | $11.6M | |
Change in Inventories | $18M | -$129.7M | -$39M | -$34.5M | $29M | |
Cash From Operations | $504.1M | $287.3M | $343.2M | $546.2M | $516.8M | |
Capital Expenditures | $48.7M | $80.1M | $165.4M | $172.7M | $149.5M | |
Cash Acquisitions | -$23.2M | -$13M | -- | -- | -- | |
Cash From Investing | $29.5M | -$74.5M | -$243.1M | -$282.2M | -$152M | |
Dividends Paid (Ex Special Dividend) | -$117.5M | -$114.6M | -$112.6M | -$111.8M | -$109.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$207.4M | -$298.2M | -$67M | -$163M | -$232.7M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$356.2M | -$389M | -$160.3M | -$234.5M | -$327.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $177.4M | -$176.2M | -$60.3M | $29.6M | $37.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $455.3M | $207.1M | $177.8M | $373.5M | $367.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $113.5M | $87.5M | $97.6M | $108.2M | $94.9M | |
Depreciation & Amoritzation | $25.6M | $24.7M | $24M | $24M | $25.5M | |
Stock-Based Compensation | $5.9M | $6.8M | $8.5M | $10.5M | $8.7M | |
Change in Accounts Receivable | $7.3M | -$31.7M | -$56.4M | -$19.8M | -$35.3M | |
Change in Inventories | -$6.8M | -$46.5M | $2.6M | -$34.1M | $27.6M | |
Cash From Operations | $190.8M | $116M | $120.9M | $129.9M | $148.5M | |
Capital Expenditures | $12.6M | $23.9M | $42.8M | $31.9M | $36.7M | |
Cash Acquisitions | -$12M | -- | -- | -- | -- | |
Cash From Investing | -$40.6M | -$2M | -$72.4M | -$55.1M | -$5.1M | |
Dividends Paid (Ex Special Dividend) | -$29.2M | -$28.6M | -$28.1M | -$27.8M | -$27.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$97.7M | -$71.3M | -$25.7M | -$41.2M | -$67.8M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$117.7M | -$96.5M | -$47.8M | -$52.2M | -$90.2M | |
Beginning Cash (CF) | $423.4M | $262.3M | $218.8M | $226.4M | $233.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $32.6M | $17.4M | $697.5K | $22.6M | $53.2M | |
Ending Cash (CF) | $455.9M | $279.7M | $219.5M | $249M | $286.6M | |
Levered Free Cash Flow | $178.2M | $92.1M | $78.1M | $98M | $111.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.